Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 327 followers
Latest posts
Last updated about 9 hours ago
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study
about 9 hours ago
Novo Nordisk’s GLP-1/amylin combo has topped blockbuster semaglutide in a phase 3...
GSK plans to lay off up to 350 R&D workers across US, UK
about 10 hours ago
GSK is trimming its R&D team, a move that is expected to...
Thermo Fisher trims Massachusetts headcount with Franklin site closure
about 11 hours ago
Thermo Fisher is continuing its recent layoff spree with a fresh round...
GSK gives back rights to Wave's genetic disease RNA editor
about 13 hours ago
Wave Life Sciences has the fate of its lead RNA editing candidate...
Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again
about 14 hours ago
Daiichi Sankyo’s development of ADCs continues to hit turbulence. The company has...
China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug
about 14 hours ago
Having already secured regional rights to vTv Therapeutics’ inflammation drug, China’s Newsoara...
Skye links CB1-Wegovy combo to 22.3% weight loss after a year in extension of failed ph. 2 study
about 15 hours ago
Skye Bioscience has published 52-week data on its investigational obesity drug combination...
Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative
about 16 hours ago
Optellum, a 2016 spinout from the University of Oxford, has been tapped...
Roche's return to RNA continues with $1.7B deal for Sanegene program
about 16 hours ago
Roche is continuing its return to the RNAi space by paying $200...
Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health
about 16 hours ago
As biotech and other sectors of the life sciences industry espouse cautious...
A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders
about 16 hours ago
Staar Surgical has endured a whirlwind start to the New Year with...
AstraZeneca study finds 22 genes tied to chronic disease risk after Epstein-Barr infection
about 18 hours ago
Nine in 10 people worldwide have been infected with Epstein-Barr virus. But...